Here to help you get the Rituxan your doctor prescribed.
Patients were given European Union–approved rituximab + short-term steroids in a clinical study to measure their lesion improvement
*The generic name for Rituxan is rituximab.
Pemphigus Vulgaris (PV) is a rare autoimmune disease that causes painful blistering of the skin and mucous membranes. Rituxan® (rituximab) is the first FDA-approved treatment for adults with moderate to severe PV. Discover more about PV and how it affects your body and how Rituxan may help.
Rituxan is administered as an intravenous infusion by your healthcare provider. Treatment involves infusions provided over several weeks. Your healthcare provider will guide you on preparing for treatment and ensuring the regimen aligns with your health condition.
Common side effects of Rituxan include infusion-related reactions, fever, and weakness. Monitoring and collaboration with your care team are essential to manage risks. Learn more about treatment results and how Rituxan may help. For additional resources, explore patient support options or financial assistance to support your PV journey.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.